Início › Câncer de Fígado (Carcinoma Hepatocelular) › Illinois › Chicago
Ensaios clínicos de Câncer de Fígado (Carcinoma Hepatocelular) em Chicago, IL
16 estudos para Câncer de Fígado (Carcinoma Hepatocelular) estão buscando participantes em locais em Chicago e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #26, Chicago
National Liver Cancer Screening Trial
RecrutandoFase 4
- Northwestern University, Chicago
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
RecrutandoFase 1/2
- Local Institution - 0107, Chicago
Defining the Ablative Dose for Y-90 TARE
RecrutandoFase 2
- Northwestern University, Chicago
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
RecrutandoEstudo observacional
- RUSH University Medical Center, Chicago
- University of Chicago, Chicago
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
RecrutandoFase 3
- Research Site, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecrutandoFase 1/2
- Lurie Children's Hospital-Chicago, Chicago
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
RecrutandoFase 3
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
RecrutandoFase 2
- University of Chicago Comprehensive Cancer Center, Chicago
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
RecrutandoEstudo observacional
- Rush University Medical Center, Chicago
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
RecrutandoFase 1/2
- Northwestern University, Chicago
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RecrutandoFase 1
- Clinical Trial Site, Chicago
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
RecrutandoFase 2
- Northwestern University, Chicago
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RecrutandoFase 4
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Chicago
The Dragon PLC Trial (DRAGON-PLC)
Recrutando
- Rush University Medical Center, Chicago
Ensaios de Câncer de Fígado (Carcinoma Hepatocelular) em outras cidades
- Houston, TX31 estudos
- New York City, NY24 estudos
- Dallas, TX19 estudos
- Los Angeles, CA19 estudos
- Boston, MA18 estudos
- Cleveland, OH18 estudos
- Philadelphia, PA16 estudos
- Pittsburgh, PA15 estudos
- San Francisco, CA14 estudos
- Orange, CA14 estudos
- Jacksonville, FL14 estudos
- San Antonio, TX13 estudos
Outros estudos em Chicago
- Câncer de Pulmão de Não Pequenas Células61 estudos
- Câncer de Mama59 estudos
- Câncer (todos os tipos)51 estudos
- Câncer Metastático45 estudos
- Câncer de Próstata45 estudos
- Câncer de Pulmão41 estudos
- Obesidade41 estudos
- Câncer de Ovário36 estudos
- Câncer Colorretal34 estudos
- Acidente Vascular Cerebral34 estudos
- Insuficiência Cardíaca31 estudos
- Sobrepeso29 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.